An FDA approval of Auxilium's (AUXL) XIAFLEX today could also keep the bullish tone for the group.
One laggard has been Onyx (ONXX), so keep an eye on that one.
Tuesday, February 2, 2010
2010: The Year of Large Cap BioTech
Starting off 2010 the markets had a rough January, losing around 4% on the S&P, often a bearish indication for the year ahead, but BioTech large caps are seeing a resurgence. Breakouts are developing in Amgen (AMGN), Cephalon (CEPH), OSI Pharma (OSIP), Gilead (GILD), Genzyme (GENZ), Acorda (ACOR), Biogen (BIIB), Dendreon (DNDN), Talecris (TLCR), Regeneron (REGN), and United Therapeutics (UTHR).
An FDA approval of Auxilium's (AUXL) XIAFLEX today could also keep the bullish tone for the group.
One laggard has been Onyx (ONXX), so keep an eye on that one.
An FDA approval of Auxilium's (AUXL) XIAFLEX today could also keep the bullish tone for the group.
One laggard has been Onyx (ONXX), so keep an eye on that one.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment